Form 4: Director Nicholas Gangestad Receives Genpact RSU Grant

Director Nicholas C. Gangestad was granted 6,521 restricted share units as part of Genpact's 2017 Omnibus Incentive Compensation Plan.

Summary

• Director Nicholas C. Gangestad acquired 6,521 restricted share units (RSUs) on April 23, 2026.
• The grant was issued under the Genpact Limited 2017 Omnibus Incentive Compensation Plan.
• The RSUs are subject to continued service requirements.
• Following this transaction, the director's total beneficial ownership of common shares is 15,334.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine regulatory disclosure regarding director compensation with no material impact on the company's financial position.

Positives

• Alignment of director interests with long-term shareholder value through equity-based compensation.

Negatives

• None identified.

Risks

• Vesting is contingent upon the director's continued service to the company.

Future Outlook

The RSUs will fully vest on December 31, 2026, and will be settled in common shares on December 31, 2027, provided the director remains in service.

Industry Context

StockSavvy.ai notes that equity grants to directors are standard corporate governance practices designed to incentivize long-term oversight and strategic alignment within the professional services and IT consulting sector.

Comparison to Industry Standards

• The use of RSU grants for director compensation is consistent with standard practices for S&P 500 and mid-cap companies.
• Vesting schedules of approximately 1-2 years for director equity are common in the technology and consulting industries.

Stakeholder Impact

• Minimal impact on shareholders as this is a standard incentive compensation award.

Next Steps

• Vesting of RSUs on December 31, 2026.
• Settlement of RSUs into common shares on December 31, 2027.

Key Dates

Keywords

Genpact, G, Form 4, Insider Trading, Director Compensation, Restricted Share Units